Suchergebnisse - "4QWG6N8QKH"

PubPharm (9)

1

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

enthalten in: JAMA | 2023

von Writing Committee for the REMAP-CAP Investigators | Higgins, A. | Berry, L. | +164

CommentIn: JAMA. 2023 Jan 3;329(1):25-27. - PMID 36525259

2

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission : The ARCTIC REWIND Randomized Clinical Trial

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +18

CommentIn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

3

Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States

enthalten in: JAMA | 2020

von Vaduganathan, M. | van Meijgaard, J. | Mehra, M. | +3

4

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome : the JOQUER randomized clinical trial

enthalten in: JAMA | 2014

von Gottenberg, J. | Ravaud, P. | Puéchal, X. | +20

5

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy : a randomized controlled trial

enthalten in: JAMA | 2012

von Paton, N. | Goodall, R. | Dunn, D. | +66

CommentIn: JAMA. 2012 Jul 25;308(4):405-6. - PMID 22820794

6

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis

enthalten in: JAMA | 2011

von Solomon, D. | Massarotti, E. | Garg, R. | +3

CommentIn: JAMA. 2011 Jun 22;305(24):2573-4. - PMID 21693749

7

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

enthalten in: JAMA | 2007

von Wasko, M. | Hubert, H. | Lingala, V. | +4

CommentIn: JAMA. 2007 Nov 28;298(20):2368-9; author reply 2369-70. - PMID 18042914

8

Progress in the treatment of rheumatoid arthritis

enthalten in: JAMA | 2001

von Pisetsky, D. | St Clair, E.

9

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

enthalten in: JAMA | 1982

von McCarty, D. | Carrera, G.

1
[1]